Antiangiogenic strategies in neuroblastoma

Domenico Ribatti, Mirco Ponzoni

Research output: Contribution to journalArticlepeer-review


Promising new antiangiogenic strategies are emerging for the treatment of cancer and the inhibition of angiogenesis could represent a powerful adjunct to traditional therapy of malignant tumors. Over the last ten years several reports have been published concerning the relationship between tumor progression and angiogenesis in neuroblastoma in experimental models in vitro and in vivo. Moreover, a high vascular index in neuroblastoma correlates with poor prognosis, suggesting dependence of aggressive tumor growth on active angiogenesis. Here, we present an overview of recent advances in antiangiogenesis in neuroblastoma and describe the most important active substances, preclinical and clinical data, as well as future pespectives.

Original languageEnglish
Pages (from-to)27-34
Number of pages8
JournalCancer Treatment Reviews
Issue number1
Publication statusPublished - Feb 2005


  • Antiangiogenesis
  • Neuroblastoma
  • Tumor progression

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'Antiangiogenic strategies in neuroblastoma'. Together they form a unique fingerprint.

Cite this